Stereotaxis, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| STXS | AHC.AX | ANGO | UTMD | MLSS | TFX | |
|---|---|---|---|---|---|---|
| Market cap | 95.91M | 103.06M | 515.17M | 206.20M | 29.81M | 6.35B |
| P/E (TTM) | — | 13.8 | — | 21.7 | — | — |
| Forward P/E | -6.2 | 7.9 | -108.1 | — | -9.4 | 13.7 |
| Price/book | 7.7 | 1.7 | 3.2 | 1.9 | 8.4 | 2.2 |
| Dividend yield | — | — | — | 1.73% | — | 0.91% |
| 1-year change | −70.11% | −38.98% | −1.51% | +20.72% | −26.83% | +12.18% |
| Today | +13.55% | +1.85% | +4.43% | +3.43% | +8.26% | +7.09% |
The closest companies by business and industry (Medical Instruments & Supplies). Prices may be delayed up to 20 min.
Latest news
All STXS news ›Stereotaxis Emerging Digital, AI and Automation Capabilities to be Featured at Heart Rhythm Society’s HRX 2026
New digital technologies, including Synchrony and SynX, will be featured at HRXStereotaxis CEO to join main-stage panel on Autonomous EP SystemsST... Stereotaxis Emerging Digital, AI and Automation Capabilities to be Featured at Heart…
Stereotaxis Announces First Robotic Magnetic Navigation System in Latvia
Pauls Stradiņš Clinical University Hospital installs Genesis Robotic Magnetic Navigation System, establishing the first robotic program for the tr... Stereotaxis Announces First Robotic Magnetic Navigation System in Latvia - Pauls Stradiņš…
Stereotaxis price target lowered to $3 from $4 at Citizens
Citizens analyst Daniel Stauder lowered the firm’s price target on Stereotaxis (STXS) to $3 from $4 and keeps an Outperform rating on the shares... Stereotaxis price target lowered to $3 from $4 at Citizens Citizens analyst Daniel Stauder…
Stereotaxis to Report Third Quarter 2026 Financial Results on November 10, 2026
The Manila Times ST. LOUIS, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it wil
Lake Street Reaffirms Their Buy Rating on Stereotaxis (STXS)
Lake Street analyst Frank Takkinen maintained a Buy rating on Stereotaxis today and set a price target of $3.00. According to TipRanks, Takkinen is a 2-star analyst with an average return of 0.7% and a 41.43% success rate. Takkinen covers…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- markets.businessinsider.com4
- globenewswire.com1
- manilatimes.net1
- stocktitan.net1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 7 articles, not a forecast.